Researchers have developed a drug shown to significantly extend survival time for patients with glioblastoma, the most common primary brain tumor in adults, according to results of a new trial.

A drug developed at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has been shown to ...

An investigational drug for glioblastoma more than doubled survival and progression-free time compared to standard rates. | Drug Discovery And Development ...

for doses greater than 100 gray (Gy), referring to units of radiation. Importantly, they did not observe any dose-limiting toxic effects, with most adverse effects deemed unrelated to the study ...

A drug developed at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has been shown to extend survival for patients with glioblastoma, the most common primary brain ...

Walmart partners with Black Heart Association, Bexa, and 4Kira4Moms at Women of Power, offering health screenings, education, ...

A drug developed at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has been shown ...

The first of the nation’s 66 F-16 Block 70 jets is soon to roll off the Lockheed-Martin production line in the US, with Taiwan intending to send deputy minister-level officials to attend the event ...

For roughly about 65 million years, the forests of the Amazonian were resilient to changes in the climate. But that is ...

D printing is revolutionizing surgical approaches. Find out how 3D printing is used for surgical planning here!